United Biopharmaceutical Inc. (4119) Q1 2026 EPS: 0.17 NTD
NQ Score
0/100
N1 Content Completeness
0
Key facts
- United Biopharmaceutical Inc. (4119) Q1 2026 EPS: 0.17 NTD
- United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.
- Source: TWSE
- Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.
- Citation
- United Biopharmaceutical Inc. (4119) Q1 2026 EPS: 0.17 NTD (Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.
AI Analysis
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.
- Q: What is the direct answer?
- A: United Biopharmaceutical Inc. (4119) reported Q1 2026 results with EPS of 0.17 NTD, revenue of 376 million NTD, and net profit of 20 million NTD in the biotechnology and healthcare industry.
- Q: What is the source and date?
- A: Source: https://openapi.twse.com.tw/financial/twse-fin-4119-2026Q1 | Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)